157 related articles for article (PubMed ID: 32311939)
1. Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer: A preliminary study.
Tokuda Y; Yanagawa M; Minamitani K; Naoi Y; Noguchi S; Tomiyama N
Medicine (Baltimore); 2020 Apr; 99(16):e19664. PubMed ID: 32311939
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
3. Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
Nam KJ; Park H; Ko ES; Lim Y; Cho HH; Lee JE
Medicine (Baltimore); 2019 Jun; 98(23):e15871. PubMed ID: 31169691
[TBL] [Abstract][Full Text] [Related]
4. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
[TBL] [Abstract][Full Text] [Related]
5. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
7. A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores.
Wan T; Bloch BN; Plecha D; Thompson CL; Gilmore H; Jaffe C; Harris L; Madabhushi A
Sci Rep; 2016 Feb; 6():21394. PubMed ID: 26887643
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Clin Radiol; 2018 May; 73(5):460-466. PubMed ID: 29295753
[TBL] [Abstract][Full Text] [Related]
9. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
10. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
11. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
12. Radiological predictive factors on preoperative multimodality imaging are related to Oncotype DX recurrence score in estrogen-positive/human epidermal growth factor receptor 2-negative invasive breast cancer: a cross-sectional study.
Tsukada H; Tsukada J; Ochi T; Noguchi E; Okamoto T
Ann Nucl Med; 2022 Oct; 36(10):853-864. PubMed ID: 35819628
[TBL] [Abstract][Full Text] [Related]
13. Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
Ashraf AB; Daye D; Gavenonis S; Mies C; Feldman M; Rosen M; Kontos D
Radiology; 2014 Aug; 272(2):374-84. PubMed ID: 24702725
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.
Choi EJ; Choi H; Choi SA; Youk JH
Medicine (Baltimore); 2016 Nov; 95(48):e5330. PubMed ID: 27902592
[TBL] [Abstract][Full Text] [Related]
15. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
[TBL] [Abstract][Full Text] [Related]
16. Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer.
Tsukamoto F; Arihiro K; Takahashi M; Ito KI; Ohsumi S; Takashima S; Oba T; Yoshida M; Kishi K; Yamagishi K; Kinoshita T
BMC Cancer; 2021 Oct; 21(1):1077. PubMed ID: 34610807
[TBL] [Abstract][Full Text] [Related]
17. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores.
Dialani V; Gaur S; Mehta TS; Venkataraman S; Fein-Zachary V; Phillips J; Brook A; Slanetz PJ
Radiology; 2016 Aug; 280(2):370-8. PubMed ID: 26937802
[TBL] [Abstract][Full Text] [Related]
19. Improved value of whole-lesion histogram analysis on DCE parametric maps for diagnosing small breast cancer (≤ 1 cm).
Xie T; Zhao Q; Fu C; Grimm R; Gu Y; Peng W
Eur Radiol; 2022 Mar; 32(3):1634-1643. PubMed ID: 34505195
[TBL] [Abstract][Full Text] [Related]
20. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
